Abstract
Caspase-3 is a vital executioner molecule during the apoptotic process. Numerous studies have revealed the close association of caspase-3 expression and breast cancer. Nevertheless, the prognostic value of caspase-3 expression for patients with breast cancer remains uncertain. To thoroughly analyze the prognostic effect of caspase-3 expression on the clinicopathological features and survival of breast cancer, we conducted this meta-analysis. With various search strategies, electronic databases were comprehensively searched. A total of 3091 patients from 21 studies were ultimately obtained. The analysis results indicated that increased expression of caspase-3 had a negative influence on the overall survival (OS) of breast cancer (HR = 1.73, 95%CI 1.12-2.67,P= 0.014). Subgroup analyses based on race revealed that the value of caspase-3 for evaluating patients' OS was more useful in Asian patients (HR = 3.16, 95%CI 1.20-8.15,P= 0.020), and subgroup analyses based on study analytical methods revealed that caspase-3 was a risk factor for breast cancer patients in multivariate overall survival analyses (HR = 1.67, 95%CI 1.02-2.75,P= 0.044). As for the relationship between caspase-3 expression and breast cancer subtype as well as prog...Continue Reading
References
Feb 12, 1998·Annals of Internal Medicine·J LauC H Schmid
Nov 26, 1999·British Journal of Cancer·M VakkalaY Soini
May 16, 2002·Journal of Mammary Gland Biology and Neoplasia·D F HayesV Stearns
Jul 11, 2002·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·L NakopoulouP S Davaris
Dec 4, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D Del BufaloG Zupi
Dec 17, 2002·Oncogene·Eswaran DevarajanKapil Mehta
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Frédérique VégranSarab Lizard-Nacol
Jun 9, 2007·Trials·Jayne F TierneyMatthew R Sydes
Jan 30, 2008·Applied Immunohistochemistry & Molecular Morphology : AIMM·Aziza NassarCynthia Cohen
Jul 24, 2010·European Journal of Epidemiology·Andreas Stang
Jul 5, 2011·Nature Medicine·Qian HuangChuan-Yuan Li
Feb 26, 2013·Human Pathology·Ling ZhouQian Huang
Jul 13, 2013·Human Pathology·Ling ZhouQian Huang
Nov 7, 2013·Breast Cancer Research and Treatment·Charla C EngelsPeter J K Kuppen
Jun 18, 2014·British Journal of Cancer·C C EngelsE Bastiaannet
Nov 2, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N P TobinUNKNOWN TEX Trialists Group
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Feb 13, 2015·OncoTargets and Therapy·Geng JiaYilin Yang
Feb 27, 2015·Cancer Biology & Therapy·Zhang JingZhang Shulan
Mar 5, 2015·International Journal of Molecular Medicine·Bo'an ZhengXiaojun Yu
Aug 19, 2015·Virchows Archiv : an International Journal of Pathology·Hyojin KimHan Suk Ryu
Sep 13, 2015·Apoptosis : an International Journal on Programmed Cell Death·Hala Gali-MuhtasibNadine Darwiche
Oct 3, 2015·Oncotarget·Xiao FengQian Huang
Jan 17, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicola CrestiAlan V Boddy
Mar 5, 2016·Oncotarget·Meixian XiangChunhua Song
Jan 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N P TobinUNKNOWN TEX Trialists Group
Citations
Mar 11, 2020·British Journal of Biomedical Science·Z HeidariS Salimi
Sep 9, 2020·Scientific Reports·Mohammed Moustapha AnwarAhmed Hussein
Jun 3, 2018·Cancer Metastasis Reviews·Ruya ZhaoChuan-Yuan Li
Jul 26, 2019·Drug Development Research·Walaa Hamada Abd-AllahSamah Sabry Saad
Jul 25, 2021·Cancers·Reyhaneh Farghadani, Rakesh Naidu
Jun 20, 2021·Anti-cancer Drugs·Miroslav TibenskyBoris Mravec